First-in-class antispastic drug candidate to reach clinical phase is published in the prestigious life science journal, Cell. Drug candidate MPH-220 could mean new hope for millions of patients ...

A small Chinese trial compared the effects of three oral antispastic medications for 24 weeks post-coronary artery bypass grafting (CABG) in relation to spasm-induced radial artery graft failure.

Currently, there is no adequate remedy to help these suffering people, which generates an immense medical need for a new generation antispastic drugs. András Málnási-Csizmadia, co-founder of ...

However, conservative methods do not always provide long-term and complete antispastic effects in cases of spinal cord injury with severe painful spasticity. Objectives: The aim of the present ...

Among the findings of three new studies, patients with functional dyspepsia were 3.25 times more likely to have disordered sleep than healthy controls; and the muscle-relaxant and antispastic drug ...

The triazole MDL 27531, 4-methyl-3-methylsulfonyl-5-phenyl-4H-1,2,4-triazole was identified as an antispastic agent selective for protection against strychnine-induced seizures and hyperreflexia.